These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 609177)

  • 21. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
    Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
    Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Adenomas and adenocarcinomas of the urinary bladder].
    Romanenko AM
    Arkh Patol; 1973; 35(12):19-24. PubMed ID: 4360611
    [No Abstract]   [Full Text] [Related]  

  • 23. Interactions of a new antitumor agent, 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]-ethyl]amino]-9,10-anthracenedione, with nucleic acids.
    Kapuscinski J; Darzynkiewicz Z; Traganos F; Melamed MR
    Biochem Pharmacol; 1981 Feb; 30(3):231-40. PubMed ID: 7225141
    [No Abstract]   [Full Text] [Related]  

  • 24. [Exploration of possible associations of antineoplastic chemotherapeutic agents in view of their mechanisms of action (author's transl)].
    Cortinovis A; Crippa A; Sommo F; Cortinovis R; Pedroni G
    Chir Ital; 1979 Aug; 31(4):616-49. PubMed ID: 399870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proceedings: A pilot study of the variability of nuclear form and DNA content in smears of human uro-epithelial bladder tumours.
    Feneley RC; Boss JM
    Br J Cancer; 1975 Feb; 31(2):263. PubMed ID: 1164482
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of some cancerostatics on the cytology and on the nucleic acid content in Ehrlich ascites cells in vivo.
    Veselá H; Jelínek V; Kejhová I
    Neoplasma; 1965; 12(4):365-72. PubMed ID: 5854407
    [No Abstract]   [Full Text] [Related]  

  • 27. [On the question of preclinical selection of cytostatics in the area of treatment of human tumors].
    Wüst GP
    Arzneimittelforschung; 1969 May; 19(5):817-9. PubMed ID: 4184536
    [No Abstract]   [Full Text] [Related]  

  • 28. Nucleic Acid Quadruplexes and Metallo-Drugs.
    Vilar R
    Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An antineoplastic C14-labeled methylhydrazine derivative in P815 mouse leukemia. A metabolic study.
    Kreis W; Yen W
    Experientia; 1965 May; 21(5):284-6. PubMed ID: 5841267
    [No Abstract]   [Full Text] [Related]  

  • 30. [Studies on cultivation of human bladder tumors and sensitivity tests of anti-cancer drugs for human bladder tumors (author's transl)].
    Ogisu B
    Nihon Hinyokika Gakkai Zasshi; 1979 May; 70(5):504-22. PubMed ID: 470259
    [No Abstract]   [Full Text] [Related]  

  • 31. The miR-193a-3p regulated PSEN1 gene suppresses the multi-chemoresistance of bladder cancer.
    Deng H; Lv L; Li Y; Zhang C; Meng F; Pu Y; Xiao J; Qian L; Zhao W; Liu Q; Zhang D; Wang Y; Zhang H; He Y; Zhu J
    Biochim Biophys Acta; 2015 Mar; 1852(3):520-8. PubMed ID: 25542424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of tryptophan and nicotinamide loads on urinary excretion of RNA metabolites by bladder cancer patients.
    Nielsen HR; Wolf H; Brown RR
    J Natl Cancer Inst; 1977 Sep; 59(3):855-8. PubMed ID: 142844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nucleic acid synthesis in ladder tumors.
    Veenema RJ; Fingerhut B; Graff S
    Trans Am Assoc Genitourin Surg; 1970; 62():155-9. PubMed ID: 5492387
    [No Abstract]   [Full Text] [Related]  

  • 34. [Oncobiograms and cancer chemotherapy: Hope or reality? (author's transl)].
    Volm M
    Langenbecks Arch Chir; 1975 Nov; 339():121-6. PubMed ID: 1207291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Flow cytometry in urinary tract malignancies. I. Cytological diagnosis by DNA histogram of exfoliative cells in bladder cancer (author's transl)].
    Akiyama T; Nagai N; Matsuura T; Iguchi M; Yachiku S; Kurita T
    Nihon Hinyokika Gakkai Zasshi; 1981 Feb; 72(2):178-84. PubMed ID: 7019526
    [No Abstract]   [Full Text] [Related]  

  • 36. [Nucleic acid metabolism in hepatomas with different degrees of differentiation].
    Bogdanov GN; Shmonina VM
    Izv Akad Nauk SSSR Biol; 1978; (3):473-6. PubMed ID: 207756
    [No Abstract]   [Full Text] [Related]  

  • 37. [In vitro-determination of the cytostatic sensitivity of malignant tumours (author's transl)].
    Stiller KJ; Löbe LP
    Arch Klin Exp Ohren Nasen Kehlkopfheilkd; 1973 Oct; 204(3):229-35. PubMed ID: 4588645
    [No Abstract]   [Full Text] [Related]  

  • 38. Nucleic acids-hybridization studies in normal and cancer cells.
    Valladares Y; Alvarez Y; Tabarés E; Pintado T
    Eur J Cancer (1965); 1970 Aug; 6(4):335-47. PubMed ID: 5485267
    [No Abstract]   [Full Text] [Related]  

  • 39. Methylation of nucleic acids in Krebs II ascites tumour cells.
    Burdon RH
    Nature; 1966 May; 210(5038):797-9. PubMed ID: 5958444
    [No Abstract]   [Full Text] [Related]  

  • 40. Determination of individual human tumour sensitivity to antitumour agents by tissue-slice incubation.
    Willoughby HW; Maughan GB; Tremblay PC; Wood N
    Can J Surg; 1971 Nov; 14(6):406-9. PubMed ID: 5170129
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.